What does delaying childbearing cost?March 15, 2012
Freezing eggs or ovarian tissue for the sole purpose of delaying childbearing for social reasons may prove too costly for society, according to a recent analysis by a University of Illinois at Chicago researcher.
Fertility preservation -- freezing eggs or ovarian tissue -- was originally intended for women undergoing medical treatments that could affect their fertility.
But now, fertility centers around the country are offering these technologies to women who are not undergoing treatment, but who are "trying to create a backup plan for delaying pregnancy," says Dr. Jennifer Hirshfeld-Cytron, assistant professor of obstetrics and gynecology at UIC and lead author of the study, published in the March issue of Fertility and Sterility.
Using decision-analysis techniques, the researchers compared the cost-per-live-birth for three alternative strategies a 25-year-old woman might use if she wants to delay childbearing until age 40.
Those scenarios included doing nothing (no cryopreservation), freezing eggs, or freezing ovarian tissue. The cost of each technique was based on published data.
"We found, in order to create one additional live birth with the mechanisms of freezing either ovarian tissue or freezing eggs, it would cost society an additional $130,000," said Hirshfeld-Cytron, director of the fertility preservation program at the University of Illinois Hospital & Health Sciences System.
In the statistical model, women at age 40 would attempt natural conception for six months before using assisted reproductive technology. After trying unsuccessfully to get pregnant on her own, the woman would either receive the standard of care (in vitro fertilization), or she would utilize either the frozen ovarian tissue or frozen eggs.
The analysis showed that freezing eggs was less expensive than freezing ovarian tissue, and doing nothing was the most cost-effective.
"In any scenario where a woman has undergone a procedure to freeze eggs or part of her ovaries for future use, and then she changes her mind, that is tissue that is never used," Hirshfeld-Cytron said. "The cost estimates in our study are actually very conservative."
Like all medical specialties, obstetrics and gynecology sometimes "can be victim to the tyranny of technology," Hirshfeld-Cytron said. Clinicians get excited about new options and offer them to a wider range of patients.
"Whether or not this is cost-effective is something that needs to be talked about and potentially decided as a society," said Hirshfeld-Cytron.
"It's also possible to argue that we could perhaps avoid these costs by providing an environment for young women that fosters career development and family-building at the same time," she said.
Co-authors are Dr. William Grobman and Dr. Magdy Milad of Northwestern University.
An extended interview as MP3 audio file is available at http://bit.ly/zbAAv8
For more information about the University of Illinois Hospital, visit www.hospital.uillinois.org
University of Illinois at Chicago
Related Ovarian Tissue Current Events and Ovarian Tissue News Articles
Researchers build functional ovarian tissue in lab
A proof-of-concept study suggests the possibility of engineering artificial ovaries in the lab to provide a more natural option for hormone replacement therapy for women.
New chemo drug gentler on fertility, tougher on cancer
A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine® scientists to be less toxic to a young woman's fertility but extra tough on cancer.
New IVF breakthrough
Researchers at the University of Gothenburg have discovered that a chemical can trigger the maturation of small eggs to healthy, mature eggs, a process that could give more women the chance of successful IVF treatment in the future.
Mass. General researchers isolate egg-producing stem cells from adult human ovaries
For the first time, Massachusetts General Hospital (MGH) researchers have isolated egg-producing stem cells from the ovaries of reproductive age women and shown these cells can produce what appear to be normal egg cells or oocytes.
Birth after cancer treatment with removal and storage of ovary
For the first time in Germany, a woman has given birth to a child after removal and preservation of tissue from one of her ovaries.
Planning for Life Beyond a Cancer Diagnosis
Five years ago, Sheri Scott was beginning a new chapter in her life. The recently engaged 31-year-old was eagerly browsing bridal magazines and busy planning for her big day.
New hybrid imaging device shows promise in spotting hard-to-detect ovarian cancer
By combining three previously unrelated imaging tools into one new device, a team of researchers from the University of Connecticut and the University of Southern California has proposed a new way to diagnose early-stage ovarian cancer in high-risk women through minimally invasive surgery.
Cancer stem cells recruit normal stem cells to fuel ovarian cancer, U-M study finds
Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.
Enzyme may drive breast cancer growth
A recently discovered enzyme drives the production of a potent form of estrogen in human breast cancer tissue, researchers from the University of Illinois at Chicago College of Medicine have found.
ENERCA clinical recommendations for sickle cell disease management and prevention in children
ENERCA is a European Network for Rare and Congenital Anaemias funded by the European Commission and coordinated by IDIBAPS - Hospital Clínic of Barcelona.
More Ovarian Tissue Current Events and Ovarian Tissue News Articles